Tumor Growth Rate Provides Useful Information to Evaluate Sorafenib and Everolimus Treatment in Metastatic Renal Cell Carcinoma Patients: An Integrated Analysis of the TARGET and RECORD Phase 3 Trial Data

✍ Scribed by Ferté, Charles; Koscielny, Serge; Albiges, Laurence; Rocher, Laurence; Soria, Jean-Charles; Iacovelli, Roberto; Loriot, Yohann; Fizazi, Karim; Escudier, Bernard

• Book ID: 121769160
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 694 KB
• Volume: 65
• Category: Article
• ISSN: 0302-2838
• DOI: 10.1016/j.eururo.2013.08.010